Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study
Titel:
Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study
Auteur:
Capell, Warren H. Barnathan, Elliot S. Piazza, Gregory Spyropoulos, Alex C. Hsia, Judith Bull, Scott Lipardi, Concetta Sugarmann, Chiara Suh, Eunyoung Rao, Jaya Prakash Hiatt, William R. Bonaca, Marc P.